Advertisement
Advertisement
OGI
Organigram Global Inc. Common Shares
1.54
USDSponsored
+0.06
+4.39%
Feb 06, 15:59 UTC -5
Closed
After-Market
1.54
0.00
-0.32%
OGI Earnings Reports
Positive Surprise Ratio
OGI beat 17 of 37 last estimates.
46%
Next Report
Next Week
Date of Next Report
Feb 09, 2026
Estimate for Q1 26 (Revenue/ EPS)
$73.88M
/-$0.01
Implied change from Q4 25 (Revenue/ EPS)
-7.72%
/-96.97%
Implied change from Q1 25 (Revenue/ EPS)
+72.90%
/-95.00%
Organigram Global Inc. Common Shares earnings per share and revenue
On Dec 16, 2025, OGI reported earnings of -0.33 USD per share (EPS) for Q4 25, missing the estimate of -0.01 USD, resulting in a -2519.05% surprise. Revenue reached 80.06 million, compared to an expected 73.75 million, with a 8.56% difference. The market reacted with a +8.89% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 73.88 million USD, implying an decrease of -96.97% EPS, and decrease of -7.72% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.56
Surprise
0.00%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
Haemonetics Corporation
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.26
Actual
$1.31
Surprise
+3.75%
FAQ
What were Organigram Global Inc. Common Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Organigram Global Inc. Common Shares reported EPS of -$0.33, missing estimates by -2519.05%, and revenue of $80.06M, 8.56% above expectations.
How did the market react to Organigram Global Inc. Common Shares's Q4 2025 earnings?
The stock price moved up 8.89%, changed from $1.80 before the earnings release to $1.96 the day after.
When is Organigram Global Inc. Common Shares expected to report next?
The next earning report is scheduled for Feb 09, 2026.
What are the forecasts for Organigram Global Inc. Common Shares's next earnings report?
Based on 3
analysts, Organigram Global Inc. Common Shares is expected to report EPS of -$0.01 and revenue of $73.88M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement